SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-008560
Filing Date
2021-04-08
Accepted
2021-04-08 16:20:15
Documents
13
Period of Report
2021-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210408_8k.htm 8-K 35564
2 EXHIBIT 99.1 ex_239882.htm EX-99.1 25615
3 EXHIBIT 99.2 ex_239883.htm EX-99.2 4979
4 a1.jpg GRAPHIC 11754
5 slide1.jpg GRAPHIC 52857
6 slide2.jpg GRAPHIC 228718
7 slide3.jpg GRAPHIC 42354
8 slide4.jpg GRAPHIC 173709
9 slide5.jpg GRAPHIC 182320
10 slide6.jpg GRAPHIC 65365
11 slide7.jpg GRAPHIC 174060
12 slide8.jpg GRAPHIC 106231
13 slide9.jpg GRAPHIC 160679
  Complete submission text file 0001437749-21-008560.txt   1712965
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 21815139
SIC: 2834 Pharmaceutical Preparations